Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe De Wals

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 14, 2003
Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildrenMaryse Guay, Anne-Marie Clouâtre, Manon Blackburn, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Risk and prevention of meningococcal disease among education workers: A reviewPhilippe De Wals, Pierre Deshaies, Gaston De Serres, et al.
Vaccine|July 31, 2023
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, CanadaGeneviève Deceuninck, Nicholas Brousseau, Brigitte Lefebvre, et al.
BMC Microbiology|July 25, 2015
Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targetsDennis K S Law, Brigitte Lefebvre, Rodica Gilca, et al.
JAMA|July 12, 2012
Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in QuebecPhilippe De Wals, Geneviève Deceuninck, Eveline Toth, et al.
Human Vaccines|December 1, 2009
Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccineVladimir Gilca, Gaston De Serres, Nicole Boulianne, et al.
Vaccine|December 5, 2012
Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccineVladimir Gilca, Gaston De Serres, Nicole Boulianne, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 28, 2022
Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, CanadaÉlise Fortin, Philippe De Wals, Denis Talbot, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|November 5, 2021
Influenza vaccine during the 2019-2020 season and COVID-19 risk: A case-control study in QuébecJacques Pépin, Philippe De Wals, Annie-Claude Labbé, et al.
Plos One|December 5, 2012
The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strainsRodica Gilca, Geneviève Deceuninck, Brigitte Lefebvre, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 14, 2003
Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildrenMaryse Guay, Anne-Marie Clouâtre, Manon Blackburn, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Risk and prevention of meningococcal disease among education workers: A reviewPhilippe De Wals, Pierre Deshaies, Gaston De Serres, et al.
Vaccine|July 31, 2023
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, CanadaGeneviève Deceuninck, Nicholas Brousseau, Brigitte Lefebvre, et al.
BMC Microbiology|July 25, 2015
Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targetsDennis K S Law, Brigitte Lefebvre, Rodica Gilca, et al.
JAMA|July 12, 2012
Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in QuebecPhilippe De Wals, Geneviève Deceuninck, Eveline Toth, et al.
Human Vaccines|December 1, 2009
Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccineVladimir Gilca, Gaston De Serres, Nicole Boulianne, et al.
Vaccine|December 5, 2012
Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccineVladimir Gilca, Gaston De Serres, Nicole Boulianne, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 28, 2022
Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, CanadaÉlise Fortin, Philippe De Wals, Denis Talbot, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|November 5, 2021
Influenza vaccine during the 2019-2020 season and COVID-19 risk: A case-control study in QuébecJacques Pépin, Philippe De Wals, Annie-Claude Labbé, et al.
Plos One|December 5, 2012
The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strainsRodica Gilca, Geneviève Deceuninck, Brigitte Lefebvre, et al.
Pageof 13